Multiomics study in adults with phenylketonuria
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at adults with phenylketonuria (PKU) using advanced testing (called multiomics) to understand how the condition affects the body. If you took part in a previous PKU study (ECOPHEN) and are willing to give a saliva sample for DNA analysis, this trial may be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have phenylketonuria (PKU).
- Your PKU was found through a routine newborn screening test after birth.
- You took part in an earlier study called ECOPHEN and attended its final visit.
- You are able to give a saliva (spit) sample for DNA analysis.
- You have health insurance and are willing to sign a consent form for the genetic testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how adults with phenylketonuria (PKU) or hyperphenylalaninemia (HMP) are doing socially and emotionally. They will ask you and a relative who lives with you to answer questionnaires about daily life.
This study looks at how common obesity is in adults with PKU and what factors may contribute to it.
This study tests a new injection called GS1168 for adults with phenylketonuria (PKU) whose current treatments are not working well. The goal is to see if it can help control their PKU better.
This study tests a new injection called PL54 to see if it is safe and tolerable for adults with phenylketonuria (PKU), a condition where the body cannot break down an amino acid called phenylalanine. It is designed for people with high blood phenylalanine levels and may offer a new treatment option.
This study tests a new home blood test (Egoo Phe) for measuring phenylalanine levels in people with PKU, as well as in healthy adults. It aims to see if it is accurate and easy to use.
This study tests a new oral medication (MZE782) for adults with PKU. It looks at how safe and effective the drug is, and it requires you to keep your diet stable for the entire study.
Hear when a new Phenylketonuria (PKU) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.